Effect of upadacitinib on extraintestinal manifestations in patients with moderately to severely active Crohn's disease

被引：0

作者：

Wright, Emily K. ^{[1
,2
]}

Colombel, Jean-Frederic ^{[3
]}

Hudesman, David ^{[4
]}

Cao, Qian ^{[7
]}

Ghosh, Subrata ^{[8
]}

Reinisch, Walter ^{[9
]}

Lacerda, Ana ^{[5
]}

Dubcenco, Elena ^{[5
]}

Doshi, Chirag ^{[5
]}

Anyanwu, Samuel ^{[5
]}

Feng, Tian ^{[5
]}

Rubin, David ^{[6
]}

机构：

[1] St Vincents Hosp, Melbourne, Vic, Australia

[2] Univ Melbourne, Melbourne, Vic, Australia

[3] Icahn Sch Med Mt Sinai, Div Gastroenterol, New York, NY USA

[4] NYU Langone Hlth, Div Gastroenterol, Ctr Inflammatory Bowel Dis, New York, NY USA

[5] AbbVie Inc, N Chicago, IL USA

[6] Univ Chicago Med, Ctr Inflammatory Bowel Dis, Chicago, IL USA

[7] Zhejiang Univ, Sir Run Shaw Hosp, Ctr Inflammatory Bowel Dis, Coll Med,Dept Gastroenterol, Hangzhou, Peoples R China

[8] Univ Coll Cork, Coll Med & Hlth, Cork, Ireland

[9] Med Univ Vienna, Clin Dept Gastroenterol & Hepatol, Vienna, Austria

来源：

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2024年 / 39卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：159 / 160

页数：2

共 50 条

[1] Upadacitinib improves symptomatic responses in patients with moderately to severely active Crohn's disease
Blumenstein, I.
Torres, J.
Ma, C.
Lindsay, J. O.
Ungaro, R.
Thin, L.
Lacerda, A. P.
Anyanwu, S. I.
Garrison, A.
Ford, S.
Louis, E.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : II000 - I1001
[2] Corticosteroid-Sparing Effect of Upadacitinib in Patients With Moderately-to-Severely Active Crohn's Disease
Dubinsky, Marla C.
D'Haens, Geert
Dewit, Olivier
Juillerat, Pascal
Panaccione, Remo
Fujii, Toshimitsu
Lacerda, Ana P.
Dubcenco, Elena
Anyanwu, Samuel I.
Doshi, Chirag
Liu, Jianzhong
Garrison, Andrew
Loftus, Edward V.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S886 - S887
[3] Efficacy of Induction upadacitinib Therapy in Chinese Patients with Moderately to Severely Active Crohn's Disease
Chen, M.
Gao, X.
Cao, Q.
Zhang, X.
Chen, Y.
Hou, X.
Zhong, J.
Sun, Y.
Phaleng, X.
JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1213 - I1213
[4] Corticosteroid discontinuation and clinical outcomes in patients with moderately to severely active Crohn's disease treated with upadacitinib
Thin, L.
Dubinsky, M.
D'Haens, G.
Dewit, O.
Juillerat, P.
Panaccione, R.
Fujii, T.
Lacerda, A.
Dubcenco, E.
Anyanwu, S.
Doshi, C.
Mallick, M.
Garrison, A.
Liu, J.
Loftus, E., Jr.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 127 - 128
[5] CORTICOSTEROID DISCONTINUATION AND CLINICAL OUTCOMES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE TREATED WITH UPADACITINIB
Dubinsky, Marla C.
D'Haens, Geert
Dewit, Olivier
Juillerat, Pascal
Panaccione, Remo
Fujii, Toshimitsu
Lacerda, Ana P.
Dubcenco, Elena
Anyanwu, Samuel
Doshi, Chirag
Mallick, Madhuja
Garrison, Andrew
Liu, Jianzhong
Loftus, Edward V.
GASTROENTEROLOGY, 2023, 164 (06) : S1087 - S1088
[6] Corticosteroid discontinuation and clinical outcomes in patients with moderately to severely active Crohn's disease treated with upadacitinib
Dubinsky, Marla C.
D'Haens, Geert
Dewit, Olivier
Juillerat, Pascal
Panaccione, Remo
Fujii, Toshimitsu
Lacerda, Ana P.
Dubcenco, Elena
Anyanwu, Samuel
Doshi, Chirag
Mallick, Madhuja
Garrison, Andrew
Liu, John
Loftus, Edward V., Jr.
SWISS MEDICAL WEEKLY, 2023, 153 : 9S - 10S
[7] Corticosteroid discontinuation and clinical outcomes in patients with moderately to severely active Crohn's disease treated with upadacitinib
Dubinsky, M. C.
D'Haens, G.
Dewit, O.
Juillerat, P.
Panaccione, R.
Fujii, T.
Lacerda, A. P.
Dubcenco, E.
Anyanwu, S.
Doshi, C.
Mallick, M.
Garrison, A.
Liu, J.
Loftus, E. V., Jr.
JOURNAL OF CROHNS & COLITIS, 2023, 17 : I104 - I106
[8] Endoscopic and clinical outcomes of upadacitinib in patients with moderately to severely active Crohn's disease by number and type of prior biologics
Peyrin-Biroulet, L.
Parkes, G.
Rodriguez, C.
Siffledeen, J.
Wright, J.
Broide, E.
Ford, S.
Lacerda, A. P.
Oomen, J.
Garrison, A.
Berg, S.
Rubin, D. T.
JOURNAL OF CROHNS & COLITIS, 2023, 17 : I20 - I22
[9] ENDOSCOPIC AND CLINICAL OUTCOMES OF UPADACITINIB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE BY NUMBER AND TYPE OF PRIOR BIOLOGICS
Peyrin-Biroulet, Laurent
Parkes, Gareth C.
Gutierrez, Cristina Rodriguez
Siffledeen, Jesse
Wright, John P.
Broide, Efrat
Ford, Sharanya
Lacerda, Ana P.
Oomen, Jessica
Garrison, Andrew
Berg, Sofie
Rubin, David T.
GASTROENTEROLOGY, 2023, 164 (06) : S1094 - S1095
[10] Unemployment and disability in patients with moderately to severely active Crohn's disease
Feagan, BG
Bala, M
Yan, S
Olson, A
Hanauer, S
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2005, 39 (05) : 390 - 395

← 1 2 3 4 5 →